Biomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :
Exogenous volatile organic compound probes (EVOC Probes) enable targeted, non-invasive assessment of biological pathways. Probes are safe, easy to administer compounds that interact with characterised metabolic pathways with relevance to key disease areas. Using Breath Biopsy, EVOC Probes can be monitored non-invasively on breath, either alone or in parallel with biomarker discovery studies.
A targeted panel of compounds with established relevance for respiratory diseases enabling high confidence, non-invasive disease detection and monitoring. Each compound is supported by evidence from breath research studies of relevant respiratory diseases and disease processes. The panel is available as an aspect of Breath Biopsy Services and panels for other disease applications are in development.
Identify prospective biomarkers relevant to key disease processes through in vitro GC-MS analysis. Compatible with headspace sampling from cell cultures, macromolecular preparations and ex vivo samples. Driven by GC-Orbitrap high-resolution mass spectrometry and supported by a rigorous and comprehensive quality assurance process. Results are suitable for comparison with in vivo studies using Breath Biopsy Services.
Consumable components of the Breath Biopsy system, required for robust breath sample collection using the ReCIVA Breath Sampler as part of the Breath Biopsy Collection Station. One Kit per sample.
Reliable and reproducible, non-invasive Breath Biopsy sample collection for high-accuracy analysis of human breath. ReCIVA provides high quality sample collection alongside ease-of-use and patient safety and comfort. Samples are easy to store and transport and can be analysed using a wide range of techniques. We recommend processing Breath Biopsy samples using high-accuracy GC-MS, available through Breath Biopsy Services.
A versatile and easy to use analyzer for the detection of biomarkers in clinical samples using field asymmetric ion mobility spectrometry (FAIMS). Rapid, portable, sensitive and selective, Lonestar has wide-ranging applications for the detection and quantification of volatile organic compounds (VOCs) from a variety of sample types including feces, urine and breath.
Introducing LabSat® Research by Lunaphore, a flexible IHC/IF staining solution for the research lab
Recombinant SARS-CoV-2 Spike Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) derived from E.coli
Recombinant SARS-CoV-2 S1 Subunit Protein with C-terminal His-tag, secreted from the serum-free medium of transfected HEK293 cells. Purchase will also include one vial of normal control (Catalog #. 230-20001), the culture supernatant of HEK293 cell transfected with empty expression vector.
Recombinant SARS-CoV-2 S1 subunit protein with C-terminal His-tag, derived from the transfected human HEK293 cells.
Recombinant SARS-CoV-2 S2 Subunit Protein with C-terminal tag, derived from the transfected human HEK293 cells.
Recombinant SARS-CoV-2 Nucleocapsid Protein with C-terminal His-tag, derived from the transfected human HEK293 cells.
Recombinant Human Angiotensin-converting Enzyme 2 (ACE2) with C-terminal His-tag, derived from the transfected human HEK293 cells.
Frequently referred to as "synthetic antibodies", aptamers are single stranded DNA molecules which can specifically recognize and bind to the targeted protein.
Recombinant SARS-CoV-2, S1 Subunit Protein (RBD) with C-terminal His tag, derived from the transfected human HEK293 cells.
Recombinant SARS-CoV-2 Spike Protein, S1 Subunit derived from E.coli
Recombinant SARS-CoV-2 Spike Protein, S2 Subunit derived from E.coli
Recombinant SARS-CoV-2 Nucleocapsid Protein derived from E.coli
Use the Bio-Plex Pro Human Serology Reagent when performing Bio-Plex Pro singleplex or combined (multiplexed) assays with Bio-Plex SARS-CoV-2 N, RBD, S1, and/or S2, and/or nucleocapsid coupled magnetic beads and Human IgA, IgG, or IgM detection in human and non-human primate samples.
1 x 96-well, includes magnetic capture beads coupled with SARS-CoV-2 nucleocapsid, receptor-binding domain, spike 1, and spike 2 viral proteins, anti-human IgG detection antibody, ready-to-use positive control, ready-to-use negative control, wash buffer, assay buffer, serology sample diluent, detection antibody diluent, streptavidin-PE, 96-well flat-bottom plate, and sealing tape.
Provides sensitive and specific quantitation of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.
Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.
RareCyte is a full-service provider of Precision Biology™ services utilizing best in class platforms for both spatial biology and liquid biopsy. We deliver quality-focused, end-to-end services from custom assay development to clinical trial testing for researchers, translational scientists, and drug development and diagnostics organizations. Explore Spatial Biology Services and Liquid Biopsy Services.
From picolitre to microliter, contact and non-contact dispensing technology combined in one highly automated production environment. The iZERO is M2-Automation`s ultra-fast, high-precision and fully flexible production line.
Single molecule array (Simoa) testing is a protein detection technique that is orders of magnitude more sensitive than standard sandwich based immunoassay techniques. Traditional ELISA measurements are limited to pg/ml levels of detection. The RayBio Ultrasensitive Simoa Testing Services can achieve sensitivity as low as femtogram (fg/ml) levels, allowing the quantification of biomarkers at concentrations previously difficult…
